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It is well known that with aging the immune response decreases. Most of the effector functions occur through specific 
receptors. Thus, we investigated the effects of various stimulants, acting through receptors or directly through the GTP- 
binding Gi protein, on phosphatidylinositol breakdown in PMNLs of young and elderly subjects and try to modulate 
it. A marked decrease in inositol phosphate (IP,, IP,, IP,) formation in PMNLs of elderly was found under FMLP stimu- 
lation when compared to that of young subjects. Neither GTPyS, nor AIF,- could induce an increase of IP, in PMNLs 
of elderly comparable to that of young subjects. The results suggest hat at ieast an alteration exists at the GTP-binding 
G, protein level, as well as in the mechanism of linkage of the receptor to the G protein. 
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1. INTRODUCTION 
It is well known that elderly subjects are prone 
to infections, cancer and autoimmune disorders 
[l-3]. The immune functions were extensively 
studied in aged humans and other animals and the 
results suggest hat the B and T lymphocyte func- 
tions are altered [4-61. In our previous studies we 
have demonstrated that phagocytic cell functions 
were also altered with aging [7,8]. It is thought that 
this decline contributes largely to the increased in- 
cidence of the above mentioned diseases. Most of 
the effector functions that occur during the im- 
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mune response necessitate the stimulation of 
specific receptors [9- 151. 
In PMNLs, as in many cells, the turnover of 
phosphoinositides is controlled by guanine 
nucleotide-binding G proteins. G proteins are ac- 
tivated when GTP is bound and inactivated when 
bound GTP is hydrolyzed. A large amount of in- 
formation is now available on the signal transduc- 
tion mechanisms of various receptors linked to 
GTP-binding Gi proteins [16-181 in the case of 
cells from young subjects, whereas this is not yet 
completely elucidated in cells of the elderly. Thus 
the aim of our present work was to study the ef- 
fects of various stimulants acting through recep- 
tors or directly through the GTP-binding Gi 
protein, on phosphatidylinositol breakdown in 
PMNLs of young and elderly subjects and try to 
modulate it. 
2. MATERIALS AND METHODS 
2.1. Patients 
PMNLs were obtained from 10 healthy young (~30 yr) and 
10 healthy old (>65 yr) subjects. All of them gave fully inform- 
ed consent and were volunteers. The selection of these persons 
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was based on the criteria of good physical and mental health 
confirmed by careful clinical and laboratory investigations [19]. 
2.2. PMNL 
PMNLs were separated by Ficoll-Hypaque density-gradient 
centrifugation according to the method of Boyum [20]. The 
cells were viable at least 95% as judged by trypan blue ex- 
clusion. 
2.3. Moteriols 
N-Formyl-methionyl-leucyl-phenylalanine (FMLP, lo-* M), 
neomycin, chloroquine, GTPyS (200 ng/ml) were from Sigma; 
pertussis toxin was from List Biological Laboratories; myo- 
[2-3H]inositol was from Amersham (spec. act. 
614 GBq/mmol). 
2.4. Experimental conditions 
The cells were resuspended in HBSS medium with or without 
1 mM Ca*+. The incubations were carried out in a CO2 in- 
cubator (CO2 5%, air 95%, humidity 95070 at37°C). The prein- 
cubation times with various inhibitors were the following: for 
500 ng/ml PT, 2 h; for 10e4 M neomycin, for 10 min; 10e4 M 
chloroquine, 30 min. myo-[2-‘Hlinositol loading: to 1 x 10’ 
cells/ml, 20&i/ml myo-(Z”H]inositol was added and in- 
cubated for 2 h at 37V. After this incubation the cells were 
washed with warm HBSS and diluted to 5 x ld cells/ml. After 
adding stimulators (lo-* M FMLP; 10 mM AlF4) to the cell 
suspension the reaction was stopped with cold TCA at a final 
concentration of 6%. In experiments with GTPyS (200 ng/ml) 
the cells were saponified (15 pg/ml saponin, 5 min) in HBSS 
without Ca*+. The preincubations with inhibitors were carried 
out during loading with myo-[2-3H]inositol. The lipids were ex- 
tracted with chloroform/methanol/HCl (100: 50: 1, v/v%) and 
the aqueous phase was used for 1Ps determination. 
Separation of inositol phosphates: IPs were separated on a 
Dowex 1 x 8 ion exchanger (formate form) with an increasing 
concentration of ammonium-formate [21]. The activity of 
samples was measured in a Hitachi liquid scintillation counter. 
3. RESULTS 
At first we investigated the well-known 
phosphoinositide mobilizing effect of FMLP on 
PMNLs of young and elderly subjects. We found 
a marked decrease in inositol phosphate (IPi, IP2, 
IP3) formation in PMNLs of elderly under FMLP 
stimulation when compared to that of young sub- 
jects (fig. 1). All inositol phosphates were decreas- 
ed but the most marked decrease was observed in 
IP3 levels. Next the effects of GTP+, a well- 
known direct stimulator of GTP-binding Gi pro- 
tein, on phosphatidylinositol breakdown were in- 
vestigated. GTPyS induced IP3 formation in 
PMNLs of young subjects whilst its effect was very 
small in PMNLs of elderly (fig.2). The other wide- 
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Fig. 1. FMLP-stimulated inositol phosphate (m IPI; •4 Ip2; &f 
IPJ) mobilization in PMNLs of young and elderly subjects. 
ly used stimulator for phosphatidylinositol 
breakdown is AlFi. A marked IPs formation 
could be observed in the case of young subjects 
(fig.3). The effects of AlFZ on IP3 formation in 
PMNLs of elderly was similar to that of GTPyS 
(figs 2,3). The effects of different inhibitors on 
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Fig.2. GTPyS (200 ng/ml)-stimulated inositol 1,4,5-trisphos- 
phate formation in saponified PMNLs of young (0) and 
elderly (0) subjects. 
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Fig.3. AlFh (10 mM)-stimulated inositol 1,4,Strisphosphate 
formation in PMNLs of young (0) and elderly (0) subjects. 
FMLP- and GTPyS-stimulated inositol phosphate 
formation were also studied (fig.4) to gain further 
understanding of the underlying mechanism of this 
age-related phosphatidylinositol breakdown 
alteration. It was found that PT, an inhibitor of 
GTP-binding Gi protein, was without any effect on 
PMNLs of the elderly, while neomycin, an in- 
hibitor of PLC, inhibited the IP formation in 
PMNLs of elderly, too. The effect of chloroquine, 
an inhibitor of PLA2, on the FMLP- and GTP+- 
induced phosphatidylinositol breakdown was very 
surprising. After the preincubation with chloro- 
quine a marked increase of inositol phosphates was 
found. The various inhibitors used did not change 
the basic IP levels (not shown). 
Fig.4. Effects of various inhibitors on FMLP- and GTPrS- 
induced inositol phosphate (B IPr; •Ii IPz; q IP3) formation 
in PMNLs of elderly subjects. PT, pertussis toxin for GTP 
binding Gi protein; Neo, neomycin for phospholipase C; Chlo, 
chloroquine for phospholipase AZ. 
The age-related changes in receptor-mediated ef- 
fector functions were extensively studied during 
these last years. It seems evident that in most cases 
the receptor number is unaffected by aging [22] 
and this disturbed responsiveness may be con- 
nected to the alteration of the receptor signal 
transduction mechanism. Based on our previous 
results and the findings of others [23] it can be 
assumed that with aging an alteration of the post- 
receptorial signal transduction mechanism occurs. 
Our results show that the PIP2 hydrolysis i.e. 
inositol phosphate formation practically could not 
be induced by FMLP in PMNLs of elderly. Thus, 
the question arises as to where the exact alteration 
is situated on the signal transduction pathway. The 
alteration could occur at various levels such as the 
receptor, the GTP-binding Gi protein, the PLC 
and finally the PIP2 availability. To get some more 
information about the alteration of PIP2 
hydrolysis, we studied the effects of direct stimula- 
tion of GTP-binding Gi protein on PIP2 hydrolysis 
and modulate them by various inhibitors. Non- 
hydrolysable analogues of GTP can retain G pro- 
teins in a functional state and allow an assessment 
of the role of G proteins. Our results show that 
neither GTPyS nor AlF4 could induce a substantial 
IP formation in PMNLs of elderly. The irrespon- 
siveness of G protein to GTPyS stimulation pro- 
vides indirect evidence of the alteration of this G 
protein with aging. This is compatible with the 
results obtained by aluminium fluoride complexes, 
which are thought to interact with G protein. Thus 
these results suggest hat at least an alteration ex- 
ists at the GTP-binding Gi protein level as well as 
in the mechanism of linkage of the receptor to the 
GTP-binding G protein. 
The fact that chloroquine, an inhibitor of PLA2 
enzyme, stimulates IP formation in PMNLs of 
elderly, suggests that (i) the elevated intracellular 
free Ca2+ level, measured in PMNLs of elderly 
[24], which could be decreased by chloroquine, in- 
hibits the PIP2 hydrolysis in PMNLs of elderly, or 
that (ii) the PLA2 pathway might exert an in- 
hibitory role on PIP2 hydrolysis in the case of 
elderly. This latter was already suggested uring 
the study of the respiratory burst with aging [25], 
but other studies also seem to suggest some sort of 
control by one pathway on the other [26]. The 
251 
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study of this phenomenon and the elucidation of 
the exact nature of this post-receptorial signal 
transduction alteration with aging need further in- 
vestigations leading to the development of new 
strategies in immunorestoration. 
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